Occurrence and distribution of Nosema ceranae in honey bee colonies in the Comoros Islands

Publication Type

Journal Article

Journal Name

Journal of Infectious Diseases

Name of Author

Kasia Stepniewska, WorldWide Antimalarial Resistance Network
Georgina S. Humphreys, WorldWide Antimalarial Resistance Network
Bronner P. Gonçalves, London School of Hygiene & Tropical Medicine
Elaine Craig, WorldWide Antimalarial Resistance Network
Roly Gosling, UCSF School of Medicine
Philippe J. Guerin, WorldWide Antimalarial Resistance Network
Ric N. Price, WorldWide Antimalarial Resistance Network
Karen I. Barnes, WorldWide Antimalarial Resistance Network
Jaishree Raman, University of Cape Town
Menno R. Smit, Liverpool School of Tropical Medicine
Umberto D'Alessandro, London School of Hygiene & Tropical Medicine
Will J.R. Stone, London School of Hygiene & Tropical Medicine
Anders Bjorkman, Karolinska Institutet
Aaron M. Samuels, Centers for Disease Control and Prevention
Maria I. Arroyo-Arroyo, Universidad de Antioquia
Guido J.H. Bastiaens, Radboud University Medical Center
Joelle M. Brown, UCSF School of Medicine
Alassane Dicko, University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology
Badria B. El-Sayed, Tropical Medicine Research Institute Sudan
Salah Eldin G. Elzaki, Tropical Medicine Research Institute Sudan
Alice C. Eziefula, London School of Hygiene & Tropical Medicine
Simon Kariuki, Kenya Medical Research Institute
Titus K. Kwambai, Liverpool School of Tropical Medicine
Amanda E. Maestre, Universidad de Antioquia
Andreas Martensson, Uppsala Universitet
Dominic Mosha, Ifakara Health Institute
Richard O. Mwaiswelo, Muhimbili University of Health and Allied Sciences
Billy E. Ngasala, Muhimbili University of Health and Allied Sciences

Publication Date

4-1-2022

Abstract

Background: Since the World Health Organization recommended single low-dose (0.25 mg/kg) primaquine (PQ) in combination with artemisinin-based combination therapies (ACTs) in areas of low transmission or artemisinin-resistant Plasmodium falciparum, several single-site studies have been conducted to assess efficacy. Methods: An individual patient meta-Analysis to assess gametocytocidal and transmission-blocking efficacy of PQ in combination with different ACTs was conducted. Random effects logistic regression was used to quantify PQ effect on (1) gametocyte carriage in the first 2 weeks post treatment; and (2) the probability of infecting at least 1 mosquito or of a mosquito becoming infected. Results: In 2574 participants from 14 studies, PQ reduced PCR-determined gametocyte carriage on days 7 and 14, most apparently in patients presenting with gametocytemia on day 0 (odds ratio [OR],0.22; 95% confidence interval [CI],. 17-.28 and OR,0.12; 95% CI,. 08-.16, respectively). Rate of decline in gametocyte carriage was faster when PQ was combined with artemether-lumefantrine (AL) compared to dihydroartemisinin-piperaquine (DP) (P=.010 for day 7). Addition of 0.25 mg/kg PQ was associated with near complete prevention of transmission to mosquitoes. Conclusions: Transmission blocking is achieved with 0.25 mg/kg PQ. Gametocyte persistence and infectivity are lower when PQ is combined with AL compared to DP.

Keywords

gametocytemia, Plasmodium falciparum, single low-dose primaquine

PubMed ID

32778875

Share

COinS